Treamid

DRUG2 trials

Sponsors

PHARMENTERPRISES LLC

Conditions

Fibrosis LungLung FibrosisSARS-CoV-2 Infection

Phase 2

Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia

CompletedNCT04527354

PHARMENTERPRISES LLCFibrosis Lung, SARS-CoV-2 Infection

Start: 2020-09-01End: 2021-02-10Updated: 2021-04-05

Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19

PHARMENTERPRISES LLCLung Fibrosis, SARS-CoV-2 Infection

Start: 2022-08-31End: 2022-12-31Target: 412Updated: 2022-08-25

Related Papers

Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial

Journal of Translational Medicine2022-11-036 citations